Clinical Trial Update: Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China [Phase 3]

View source ↗

Summary

Phase 3 trial update for lapatinib plus capecitabine in advanced/metastatic breast cancer in Chinese women; trial terminated with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lapatinib (Lapatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms, Breast | Phase 3 | Status: TERMINATED | Results posted: 2009-09-03